
ImmunityBio, Inc. ($IBRX) shows a significant short interest of 121M shares against a free float of only 89M shares, indicating a high potential for a short squeeze. This substantial short position, expiring by 12/31/2025, suggests a risky but potentially lucrative opportunity for investors.

By beaniemaxi
Crypto native since the early days. Went all in on DeFi summer. Then tripled down on NFTs. VC @gmcapital_. No paid promos. Not financial advice. I talk my book.